We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Major Effect of the Syndrome of Rapid-Onset End-Stage Renal Disease on the Use of Arteriovenous Fistulas High Rates of Initiation of Hemodialysis With Hemodialysis Catheter in the United States

Macaulay Amechi Chukwukadibia Onuigbo, MD, MSc, FWACP, MBA1,2
[+] Author Affiliations
1Mayo Clinic College of Medicine, Rochester, Minnesota
2Department of Nephrology, Mayo Clinic Health System, Eau Claire, Wisconsin
JAMA Surg. 2016;151(1):96. doi:10.1001/jamasurg.2015.2430.
Text Size: A A A
Published online


To the Editor Whereas classic teaching highlights reduced infection risk, fewer hospitalizations, and lower total costs associated with hemodialysis (HD) that is initiated via arteriovenous fistula (AVF) vs hemodialysis catheter (HC), and whereas the National Kidney Foundation–Kidney Disease Outcomes Quality Initiative1 first published practice guidelines regarding permanent HD access creation and maintenance in 1997, targeting a 50% or greater incidence rate for AVF, Malas et al2 have demonstrated in a retrospective analysis of 510 000 patients with end-stage renal disease (ESRD) in the US Renal Data System database that 82.6% of these patients initiated HD via HC, 14.0% via AVF, and 3.4% via arteriovenous graft. Arteriovenous fistula use increased only minimally, from 12.2% in 2006 to 15.0% in 2010.2 Furthermore, patients initiating HD with AVF had 35% lower mortality than those initiating HD with HC (adjusted hazard ratio, 0.65; 95% CI, 0.64-0.66; P < .001).2 As a consequence, survival at 1 year was 78% in the HC group compared with 84% for the arteriovenous graft group and 89% for the AVF group (Wilcoxon P < .001).2 Arteriovenous fistula use was associated with a 38% lower hazard of cardiovascular mortality (adjusted hazard ratio, 0.62; 95% CI, 0.61-0.64; P < .001) and with a 44% lower hazard of sepsis-related mortality (adjusted hazard ratio, 0.56; 95% CI, 0.53-0.59; P < .001).2


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





July 1, 2016
Devin S. Zarkowsky, MD; Caitlin W. Hicks, MD, MS; Mahmoud B. Malas, MD, MHS
1Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
2Division of Vascular and Endovascular Therapy, The Johns Hopkins Medical Institutes, Baltimore, Maryland
JAMA Surg. 2016;151(7):687. doi:10.1001/jamasurg.2015.5559.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...